First drug for brain damage-related obesity gets FDA approval
The US Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’ therapy for a rare form of obesity caused by brain damage, making it the first treatment to be approved in the US for the condition.
Black News 
The US Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’ therapy for a rare form of obesity caused by brain damage, making it the first treatment to be approved in the US for the condition.
